A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma

被引：0
|
作者：
Nagao, S. [1 ]
Oishi, R. [1 ]
Iwasa, N. [1 ]
Shimizu, M. [1 ]
Hasegawa, K. [1 ]
Goto, T. [1 ]
Fujiwara, K. [1 ]
机构：
[1] Saitama Med Univ Int, Med Ctr, Hidaka City, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16549
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Shibutani, Takashi
    Nagao, Shoji
    Suzuki, Kazuhiro
    Kaneda, Michiko
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Sudo, Tamotsu
    Yamaguchi, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 502 - 507
  • [42] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Takashi Shibutani
    Shoji Nagao
    Kazuhiro Suzuki
    Michiko Kaneda
    Kasumi Yamamoto
    Tomoatsu Jimi
    Hiroko Yano
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Tamotsu Sudo
    Satoshi Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 502 - 507
  • [43] Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
    Lander, Megan
    Abedin, Yasmin
    Gabrilovich, Sofia
    Marcus, Jenna Z.
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 32
  • [44] Deliverability of Carboplatin and Weekly Paclitaxel as Adjuvant Therapy for Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
    Sivakumaran, T.
    Zaheed, M.
    Freimund, A.
    Beale, P.
    Harrison, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 72 - 72
  • [45] Phase II study of intravenous (IV) bevacizumab and paclitaxel, and intraperitoneal (IP) cisplatin, followed by bevacizumab consolidation for advanced ovarian (O) or peritoneal (P) cancers
    McMeekin, D. D.
    Lanneau, G.
    Curiel, J.
    Moore, K.
    Walker, J.
    Mannel, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma
    Hess, V
    Verrill, MW
    Bomphray, CC
    Vaughan, MM
    Allen, M
    Gore, ME
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 638 - 642
  • [47] A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma
    Lisa N. Abaid
    John P. Micha
    Mark A. Rettenmaier
    John V. Brown
    Alberto A. Mendivil
    Katrina L. Lopez
    Bram H. Goldstein
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 101 - 107
  • [48] Comparative phase II study of intraperitoneal (IP) versus intravenous (IV) carboplatin administration with IV paclitaxel in patients with bulky residual disease after primary debulking surgery for epithelial ovarian or primary peritoneal cancer: A Sankai Gynecology Study Group (SGSG) study
    Fujiwara, K.
    Nagao, S.
    Kigawa, J.
    Noma, J.
    Akamatsu, N.
    Miyagi, Y.
    Numa, F.
    Okada, M.
    Aotani, E.
    Terakawa, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma
    Abaid, Lisa N.
    Micha, John P.
    Rettenmaier, Mark A.
    Brown, John V.
    Mendivil, Alberto A.
    Lopez, Katrina L.
    Goldstein, Bram H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 101 - 107
  • [50] Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
    Kim, Kidong
    Kim, Jae-Hoon
    Kim, Seung Cheol
    Kim, Yong Beom
    Nam, Byung-Ho
    No, Jae Hong
    Cho, Hanbyoul
    Ju, Woong
    Suh, Dong Hoon
    Kim, Yun Hwan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
12345